DC
DCOY
Decoy Therapeutics Inc.
$6.61
-1.49%
$3.6M
No data for this timeframe.
Vol
Market Cap$3.6M
Cap SizeNano Cap
Inst. Holders1 funds
Inst. Value$23.00
Inst. Activity1 buys / 0 sells
Reddit Sentiment50° Neutral
SEC Reports4
Recent Activity
Jun 4, 2026
SEC
Decoy Therapeutics Inc. filed a DEFA14A (definitive additional proxy soliciting materials) providing notice of its 2026
DEFA14A — Impact 3/10
May 12, 2026
earnings_calendar
DCOY Q1 2026 Earnings Scheduled — 2026-05-12
Apr 30, 2026
SEC
Decoy Therapeutics filed Amendment No. 1 to its 2025 10-K to include Part III items (directors, executive compensation,
10-K/A — Impact 2/10
Apr 2, 2026
SEC
Decoy Therapeutics Inc. (DCOY) has regained compliance with Nasdaq's $1.00 minimum bid price requirement after implement
8-K — Impact 6/10
Inst.
BANK OF AMERICA CORP — DOUBLED
36 shares ($23.00)
Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$30.00 (Jan 2026)
Current $6.61
Low $30.00
Median $30.00
High $30.00
1 analysts
$30.00
$30.00
Analyst Ratings
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jan 23, 2026 | Ladenburg Thalmann | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-2.88 | $-2.88 — $-2.88 | 1 | |
| Next Q | $-3.12 | $-3.12 — $-3.12 | 1 | |
| Current FY | $-12.96 | $-12.96 — $-12.96 | 90% YoY | 1 |
| Next FY | $-19.32 | $-19.32 — $-19.32 | -49% YoY | 1 |
Latest Reports
NEUTRAL
DEFA14A
3/10
Decoy Therapeutics Inc. filed a DEFA14A (definitive additional proxy soliciting materials) providing notice of its 2026
Jun 4, 2026
NEUTRAL
10-K/A
2/10
Decoy Therapeutics filed Amendment No. 1 to its 2025 10-K to include Part III items (directors, executive compensation,
Apr 30, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BANK OF AMERICA CORP | $23.00 | DOUBLED |
Reddit Sentiment
50°
Neutral
Bearish
Neutral
Bullish
1 institutional holders with $23.00 total value (36 shares) as of 2025-Q4. Top holders: BANK. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BANK OF AMERICA CORP /DE/ | 36 | $23.00 | 100.0% | DOUBLED +800.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | DOUBLED | 4 | 36 | +800.0% | $23.00 | 2025-Q4 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 1 mixed, 3 neutral. Avg impact: 3.8/10.
NEUTRAL
DEFA14A
3/10
Decoy Therapeutics Inc. filed a DEFA14A (definitive additional proxy soliciting materials) providing
Jun 4, 2026
NEUTRAL
10-K/A
2/10
Decoy Therapeutics filed Amendment No. 1 to its 2025 10-K to include Part III items (directors, exec
Apr 30, 2026
MIXED
8-K
6/10
Decoy Therapeutics Inc. (DCOY) has regained compliance with Nasdaq's $1.00 minimum bid price require
Apr 2, 2026
NEUTRAL
8-K
4/10
Decoy Therapeutics Inc. (DCOY) announced a 1-for-12 reverse stock split effective March 6, 2026, red
Mar 5, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Jan 2026): 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$30.00 mean target (Jan 2026)
$30.00 Low
$30.00 High
| Metric | Value |
|---|---|
| Current Price | $6.61 |
| Target Low | $30.00 |
| Target Mean | $30.00 |
| Target Median | $30.00 |
| Target High | $30.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-2.88 | $-2.88 | $-2.88 | — | — | — | $0.0B | — | 1 |
| Next Q 2026-09-30 |
$-3.12 | $-3.12 | $-3.12 | — | — | — | $0.0B | — | 1 |
| Current FY 2026-12-31 |
$-12.96 | $-12.96 | $-12.96 | 90.0% | — | 1↑ 0↓ | $0.0B | — | 1 |
| Next FY 2027-12-31 |
$-19.32 | $-19.32 | $-19.32 | -49.1% | — | 1↑ 0↓ | $0.0B | — | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-2.880 | |
| 7d ago | $0.000 | -2.880 |
| 30d ago | $0.000 | -2.880 |
| 60d ago | $0.000 | -2.880 |
| 90d ago | $0.000 | -2.880 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jan 23, 2026 | Ladenburg Thalmann | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jan 1, 2025 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Dec 1, 2024 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Nov 1, 2024 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Oct 1, 2024 | 0 | 0 | 3 | 1 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
2 mentions
0 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 30, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 30, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
May 12, 2026
earnings_calendar
DCOY Q1 2026 Earnings Scheduled — 2026-05-12
Mar 19, 2026
earnings_calendar
DCOY Q4 2025 Earnings After Market Close — 2026-03-19